Health

Low Libido? FDA Weighs Drug to Drive Women’s Desire

In this Friday, Sept. 27, 2013, file photo, a tablet of flibanserin sits on a brochure for Sprout Pharmaceuticals in the company's Raleigh, N.C., headquarters. The pill has been twice rejected, but Sprout Pharmaceuticals said Tuesday, Feb. 17, 2015, it is refiling its application for flibanserin, adding new information requested by the Food and Drug Administration about how the pill affects driving ability. (AP Photo/Allen G. Breed, File)
In this Friday, Sept. 27, 2013, file photo, a tablet of flibanserin sits on a brochure for Sprout Pharmaceuticals in the company’s Raleigh, N.C., headquarters. (AP Photo/Allen G. Breed, File)

Liz Szabo, USA TODAY

 

WASHINGTON (USA Today) — The drug makers of a  “little pink pill” touted as a boost for female sexual desire will learn its fate Tuesday when the Food and Drug Administration decides whether to approve the drug as a treatment for low libido in women.

Depending on your point of view, the pill, flibanserin — popularly, but incorrectly, dubbed the “female Viagra” — is either the answer to a woman’s prayers or a risky drug that turns a normal condition into a medical problem that only pharmaceuticals can solve. It will be FDA’s third consideration of flibanserin in five years. The agency has twice rejected the drug since 2010.

This time around, the drug benefits from a major public relations push from an advocacy group, Even the Score, which is supported by flibanserin’s manufacturer, Sprout Pharmaceuticals of Raleigh, N.C. High-profile supporters include the National Organization for Women and 11 members of Congress who wrote to the FDA on flibanserin’s behalf.

 

READ MORE

###

Tags
Show More

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *


By submitting this form, you are consenting to receive marketing emails from: Washington Informer Newspaper, 3117 Martin Luther King Jr. Ave SE, Washington, DC, 20032, http://www.washingtoninformer.com. You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact

Back to top button

My News Matters to me - Washington Informer Donations

Be a Part of The Washington Informer Legacy

A donation of your choice empowers our journalists to continue the work to better inform, educate and empower you through technology and resources that you use.

Click Here Today to Support Black Press and be a part of the Legacy!

Subscribe today for free and be the first to have news and information delivered directly to your inbox.


By submitting this form, you are consenting to receive marketing emails from: Washington Informer Newspaper, 3117 Martin Luther King Jr. Ave SE, Washington, DC, 20032, http://www.washingtoninformer.com. You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact
Close

Adblock Detected

Please consider supporting us by disabling your ad blocker